Researchers
Andrić, Zoran
Results 61-80 of 89
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2019 | Nonalcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome | Macut, Đuro   ; Bjekić-Macut, Jelica ; Livadas, Sarantis; Stanojlović, Olivera ; Hrnčić, Dragan ; Rašić-Marković, Aleksandra ; Milutinović, Danijela ; Mladenović, Violeta ; Andrić, Zoran | Article | 22M22 |
| 2019 | Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22 | Siefker-Radtke, Arlene O; Lugowska, Iwona; Tupikowski, Krzysztof; Andric, Zoran G ; Rezazadeh-Kalebasty, A; Curigliano, Giuseppe; Vaena, Daniel A; Vogl, FD; Currie, Graeme; Abella, S;
Kelly, William Kevin;
| Conference Paper | Mp. category will be shown later |
| 2019 | Effect of trilaciclib, a CDK 4/6 inhibitor, on myelosuppression in patients with previously treated extensive-stage small cell lung cancer receiving topotecan. | Hart, Lowell L; Andric, Zoran G ; ...; Radosavljevic, Davorin Z; Jovanovic, Dragana; ...; Samarzija, Miroslav; Zaric, Bojan ; ...; (broj, koautora 20) | Conference Paper | Mp. category will be shown later |
| 2019 | FIERCE-22: Clinical activity of vofatamab (V) a FGFR3 selective inhibitor in combination with pembrolizumab (P) in WT metastatic urothelial carcinoma, preliminary analysis. | Siefker-Radtke, Arlene O; Currie, Graeme; Abella, Esteban; Vaena, Daniel A; Kalebasty, Arash Rezazadeh; Curigliano, Giuseppe; Tupikowski, Krzysztof; Andric, Zoran G ; Lugowska, Iwona; Kelly, William Kevin | Conference Paper | Mp. category will be shown later |
| 2019 | Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by SP142, SP263 and 22C3 PD-L1 immunohistochemistry (IHC) assays and by blood tumour mutational burden (bTMB): Results from the IMpower110 study | Herbst, Roy S; ...; Andric, Zoran G ; ...; (broj, koautora 20) | Conference Paper | Mp. category will be shown later |
| 2019 | Relationship between distribution of LDL subfractions and NAFLD in PCOS - Effect on CV risk | Perović-Blagojević, Iva; Ignjatović, Svetlana ; Macut, Đuro ; Kotur-Stevuljević, Jelena ; Božić-Antić, Ivana ; Vekić, Jelena ; Bjekić-Macut, Jelica ; Kastratović-Kotlica, Biljana ; Andrić, Zoran ; Ilić, Dušan | Conference Paper | Mp. category will be shown later |
| 2018 | Lung cancer vaccine: Experiences in Serbia | Andric, Zoran G | Conference Paper | Mp. category will be shown later |
| 2018 | Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy | Schwartzberg, Lee Steven; Roeland, E; Andric, Zoran G ; Kowalski, Dariusz; Radic, J; Voisin, Daniel; Rizzi, Giada; Navari, R; Gralla, Richard J; Karthaus, Meinolf | Article | 21a+M21a+ |
| 2018 | Evaluation of a Summary Score for Dyslipidemia, Oxidative Stress and Inflammation (The Doi Score) in Women with Polycystic Ovary Syndrome and its Relationship with Obesity | Perović-Blagojević, Iva; Ignjatović, Svetlana ; Macut, Djuro ; Kotur-Stevuljević, Jelena ; Bozić-Antić, Ivana ; Vekić, Jelena ; Bjekić-Macut, Jelica; Kastratović-Kotlica, Biljana ; Andrić, Zoran ; Ilić, Dušan | Article | 22M22 |
| 2017 | Phase 3 safety evaluation of an intravenous formulation of NEPA, a novel fixed antiemetic combination of fosnetupitant and palonosetron | Schwartzberg, Lee Steven; Andric, Zoran G ; Kowalski, Dariusz; Voisin, Daniel; Rizzi, Giada; Karthaus, Meinolf | Conference Paper | Mp. category will be shown later |
| 2017 | Vemurafenib in metastatic melanoma treatment - Case report | Djedovic, J; Andric, Zoran G | Conference Paper | Mp. category will be shown later |
| 2017 | Phase III safety evaluation of intravenous NEPA, a novel fixed antiemetic combination of fosnetupitant and palonosetron, over multiple cycles | Schwartzberg, Lee Steven; Andric, Zoran G ; Kowalski, Dariusz; Voisin, Daniel; Rizzi, Giada; Karthaus, Meinolf | Conference Paper | Mp. category will be shown later |
| 2017 | Stent loss during pci and successful recovery using new approach | Hinić, Saša ; Klašnja, Slobodan; Andrić, Zoran ; Crnokrak, Bogdan; Milovanović, Branislav M. ; Zdravković, Marija D. | Conference Paper | Mp. category will be shown later |
| 2016 | Lipid accumulation product as a marker of cardiometabolic susceptibility in women with different phenotypes of polycystic ovary syndrome | Božić-Antić, Ivana ; Ilić, Dušan; Bjekić-Macut, Jelica ; Bogavac, Tamara; Vojnović-Milutinović, Danijela ; Kastratovic-Kotlica, Biljana ; Milić, Nataša ; Stanojlović, Olivera ; Andrić, Zoran ; Macut, Djuro | Article | 21M21 |
| 2016 | Cortisol Response to Low-Dose (1 μg) ACTH Stimulation for the Prediction of Outcome in Patients with Systemic Inflammatory Response Syndrome | Bjekić-Macut, Jelica ; Radosavljević, Vojislav; Andrić, Zoran ; Ilić, Dušan; Stanojlović, Olivera ; Vojnović-Milutinović, Danijela ; Božić Antić, Ivana ; Zdravković, Marija ; Hinić, Saša; Macut, Đuro ;
Žarković, Miloš
; | Article | 23M23 |
| 2015 | Predictors of Subclinical Cardiovascular Disease in Women with Polycystic Ovary Syndrome: Interrelationship of Dyslipidemia and Arterial Blood Pressure | Macut, Đuro ; Bačević, Marina; Božić-Antić, Ivana ; Bjekić-Macut, Jelica ; Civcic, Milorad; Erceg, Snježana; Vojnović-Milutinović, Danijela ; Stanojlović, Olivera ; Andrić, Zoran ; Kastratović-Kotlica, Biljana ;
Sukilović, Tijana
; | Article | 22M22 |
| 2015 | Gojaznost i reproduktivna funkcija žene - mehanizmi nastanka i terapijske implikacije | Bjekić-Macut, Jelica ; Božić-Antić, Ivana ; Vojnović-Milutinović, Danijela ; Stanojlović, Olivera ; Andrić, Zoran ; Ilić, Dušan; Macut, Đuro | Article | Mp. category will be shown later |
| 2014 | Multivariate analysis of prognostic factors in male breast cancer in Serbia | Šipetić-Grujičić, Sandra B. ; Murtezani, Zafir H.; Nešković-Konstatinović, Zora B. ; Marinković, Jelena M. ; Kovčin, Vladimir N. ; Andrić, Zoran G. ; Kostić, Sanja V.; Ratkov, Isidora S. ; Maksimović, Jadranka M. | Article | 22M22 |
| 2013 | A randomized study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel versus docetaxel alone for second-line therapy of lung adenocarcinoma (GALAXY-1). | Ramalingam, Suresh S; ...; Andric, Zoran G ; ...; Zaric, Bojan ; ...; Vukovic, Vojislav M; ...; (broj, koautora 20) | Conference Paper | Mp. category will be shown later |
| 2013 | Analysis of clinicopathological characteristics of 982 lung cancer patients and subsequent treatment Epidemiology study | Jovanovic, Dragana D; Secen, Nevena M; Murtezani, Zafir; Rancic, Milan H ; Kacar-Kukric, Vesna D; Velinovic, Marta; Tepavac, Ana; Budisin, Evica S; Andric, Zoran G ; Vukobradovic-Djoric, Nevena | Conference Paper | Mp. category will be shown later |